Literature DB >> 355573

Prognosis in tetanus: Use of data from therapeutic trials.

P Armitage, R Clifford.   

Abstract

There is a need in clinical tetanus for a simple prognostic classification for all patients at time of admission to the hospital. Data from three randomized clinical trials performed in India in the 1960s, which contained information on several prognostic variables for 1,385 patients, have been used to study different methods of prognosis. A logistic regression performed on the combined data from the trials suggested that the probability of death is related separately to the period of onset (the time from the first symptom to generalized reflex spasms), to the time from first symptom to admission to the hospital, and to the clinical assessment of severity of tetanus on admission; the effects of these variables have been studied by tabulation. A new system is proposed for assigning patients to three prognostic groups, defined by time from first symptom to admission and whether or not reflex spasms were present on admission to the hospital. The range of fatality rates is 10%--63%. Neonates are assigned to a separate group with a fatality rate of 72%. Other prognostic groupings are also explored in case it is felt that the above method relies too heavily on local arrangements for medical care.

Entities:  

Mesh:

Year:  1978        PMID: 355573     DOI: 10.1093/infdis/138.1.1

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Long-term continuous spinal anesthesia in severe tetanus with autonomic disturbance.

Authors:  H Sugimoto; M Shibuya; M Uenishi; J Yokota; C Terai; T Shimazu; T Megawa; T Yoshioka; T Sugimoto
Journal:  Klin Wochenschr       Date:  1987-03-02

2.  Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route.

Authors:  Demócrito de Barros Miranda-Filho; Ricardo Arraes de Alencar Ximenes; Antônio Alci Barone; Vicente Luiz Vaz; Aderbal Gomes Vieira; Valéria Maria Gonçalves Albuquerque
Journal:  BMJ       Date:  2004-03-05

3.  Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies?

Authors:  R Mick; C B Begg; K H Antman; A H Korzun; E Frei
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.